ARDX
ArdelyxยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
ARDX Profile
Ardelyx, Inc.
A biopharmaceutical company that develops small molecule therapeutics for the treatment of cardio-renal, gastrointestinal
400 Fifth Ave., Suite 210, Waltham, Massachusetts 02451
--
Ardelyx, Inc., is a clinical-stage biopharmaceutical company dedicated to the discovery, commercialization of innovative development, non-systematic small molecule drug therapy work, specializing in the gastrointestinal aspects, the treatment of heart and kidney, gastrointestinal and metabolic diseases. The company's developed drug discovery and design platform enables it to discover and design new drug candidates in a fast and cost-effective way. Founded in Delaware on October 17, 2007, the company changed its name from nteryx to ardelyx in June 2008.
